Thomas Buchholz
Directeur/Bestuurslid bij Nucleix Ltd.
Actieve functies van Thomas Buchholz
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Nucleix Ltd.
 Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | Directeur/Bestuurslid | 11-05-2020 | - |
Loopbaan van Thomas Buchholz
Opleiding van Thomas Buchholz
| Tufts University School of Medicine | Doctorate Degree |
| Bucknell University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Israël | 2 |
Operationeel
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
| Director/Board Member | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Nucleix Ltd.
Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | Health Services |
- Beurs
- Insiders
- Thomas Buchholz
- Ervaring
